By Abhay Ray 
Introduction
Ultrahuman, a Bengaluru-based healthtech and wearable startup, achieved a major milestone in FY25 by turning profitable with revenues surging nearly 5X to ₹565 crore. Best known for its smart ring that tracks health and fitness biomarkers, the company swung from losses in FY24 to reporting a net profit of ₹73 crore. This sharp turnaround was fueled by strong global demand for its hardware products and rising adoption of its subscription services, which improved overall margins. With operations spanning the US, UK, Middle East, and India, Ultrahuman’s FY25 performance underscores not only its rapid scale-up but also the growing potential of India-led innovation in the global wearable and health technology market. In this blog, we will learn about it in detail.
What is the Ultrahuman Ring Air
The Ultrahuman Ring Air Founded in 2019 by Mohit Kumar and Vatsal Singhal, Ultrahuman is a healthtech startup focused on longevity and metabolic health, tracks health, wellness and fitness metrics like heart rate, skin temperature, activity, workouts, stress and more. It automatically detects naps, sleep and some exercise like outdoor walks. You can also manually start and stop workouts or breathing exercises through the app, with dozens of profiles available. You view all of your data and insights through the Ultrahuman app, which is full of charts, graphs and scores for things like your sleep, dynamic recovery, movement index, stress rhythm and circadian rhythm.
The ring does not have a monthly subscription. There are extra features for a monthly fee, but they feel like just that: extra, not key to the core experience.
Its flagship products include the Ultrahuman Ring AIR and the Ultrahuman M1 continuous glucose monitor, both aimed at helping users optimize their health through actionable insights.
Catalysts for Profitability: Product Innovation and Supply Chain Mastery
Ultrahuman’s edge lies in its “impossible product”—Indian-made, globally scaled hardware focused on longevity. Key enablers:
Flagship Momentum: The Ultrahuman Ring Air, a Red Dot Award winner, dominates with non-intrusive tracking of sleep, HRV, and glucose via the M1 monitor. Sales hit $74.5M (₹620 Cr) in CY24, with 50% from the US.
Manufacturing Scale: Expanded Bengaluru’s UltraFactory 15X and launched a Plano, Texas facility for supply chain resilience, supporting $200M annual capacity without heavy outsourcing risks.
Diversification: Beyond rings, the pipeline includes Ultrahuman Home (indoor health monitor) and at-home blood diagnostics, targeting a full-stack ecosystem for metabolic health—a $1B+ global issue.
Market Tailwinds: Post-COVID health consciousness and competition with Oura (patent disputes notwithstanding) have boosted demand, with Ultrahuman claiming second-place sales. Reinvesting 20% of profits into R&D ensures it’s not a one-trick pony, per founder insights.
Challenges Overcome and Unicorn Ambitions and IPO Horizon
- The road wasn’t smooth: A US patent suit from Oura alleges design copying, but Ultrahuman’s in-house production and profitability buffer legal costs. FY24’s ₹39 Cr loss stemmed from scaling pains, but FY25’s efficiencies—lower ad spends and optimized procurement—flipped the script. With a $125M valuation post-Series B ($35M in 2024), the firm navigates a fiercely competitive arena (e.g., vs. Whoop, Fitbit) by prioritizing PMF in biomarkers.
- Ultrahuman eyes ₹1,000 Cr revenue soon, potentially unicorn status by 2026, with IPO plans on the cards. Breaking $100M in CY25 is feasible, per CY24’s $74.5M run rate. As India’s first profitable consumer hardware exporter in this category, it sets a blueprint for peers. Global expansion—Europe, LATAM—and AI-driven insights could propel 50%+ CAGR, though IP risks loom.
Strategic Moves & Expansion
In FY25, Ultrahuman focused on strategic growth while maintaining profitability. CEO Mohit Kumar highlighted the company’s lean approach and the scaling of its PowerPlugs subscription software, which provides advanced medical-grade insights beyond wellness. The firm expanded its product ecosystem by strengthening women’s health tracking: its subsidiary, Ultrahuman Healthcare Ltd, fully acquired viO HealthTech Ltd, enabling enhanced menstrual cycle and ovulation features within its smart rings. With a global presence across the US, UK, Middle East, and India, Ultrahuman is also positioning itself for deeper international expansion, while balancing hardware success with recurring subscription revenues to boost margins and customer stickiness.
Conclusion
Ultrahuman’s journey from a loss-making startup to a profitable global healthtech brand in FY25 reflects the power of product innovation, supply chain mastery, and a clear focus on longevity-driven health solutions. The success of the Ring Air and complementary offerings like the M1 glucose monitor demonstrate strong product–market fit, while investments in R&D, manufacturing, and global expansion ensure long-term resilience. With profitability achieved, a $1,000 crore revenue target on the horizon, and IPO ambitions in sight, Ultrahuman is poised to emerge as one of India’s first global consumer hardware unicorns. However, sustaining growth amid competition, patent disputes, and scaling challenges will define how successfully it capitalizes on its momentum.
Reliance Retail’s ₹ 40,000-Crore Bet
GetMyIndia.com RaysVeda.com GetMyStartup.com LawCanal.com ABHAYRAY.COM ZinCob.com Angeltors.com